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Aflatoxins are secondary metabolites of certain Aspergillus species, that 
contaminate staple foods, particularly in developing countries. Aflatoxin B1 
(AFB1) is the most toxic and common of the major types of aflatoxins. AFB1 is 
hepatotoxic and has been implicated in increasing the risk of hepatocellular 
carcinoma (HCC). We have previously shown that subacute exposure to AFB1 
for 7 days disrupts hepatic lipids; therefore, this study determined the time-
course effects of acute aflatoxin exposure on hepatic mitochondrial lipids and 
oxidative stress. To achieve this, thirty male albino rats were randomly 
assigned to six groups. The groups received an oral dose of 1 mg/kg body 
weight AFB1 or vehicle only (controls) for one, four, or seven days, 
respectively. Twenty-four hours after the last dose, the animals were sacrificed 
and liver excised. Mitochondria and cytosolic fractions were obtained from the 
liver after which lipids (cholesterol, triacylglycerols) were determined in the 
mitochondria while biomarkers of oxidative stress (glutathione, glutathione 
transferase (GST), glutathione peroxidase (GPx), glutathione reductase, nitric 
oxide (NO), malonaldehyde (MDA), thioredoxin reductase (TR), and 
superoxide dismutase (SOD) were determined spectrophotometrically in the 
mitochondria and cytosolic fractions. The expression of genes 
(Nrf2, Acc, Nqo1, and HmgCoa) were determined using quantitative RT-PCR. 
Results showed that AFB1 significantly increased mitochondrial cholesterol at 
day seven (treatment vs. control, p = 0.016). It also increased the 
concentrations of NO and MDA at day one and day seven while the activity of 
GPx and concentration of GSH were increased at day seven (p = 0.030) and 
day one (p = 0.025) alone, respectively, compared to control. The activities of 
cytosolic GR (p = 0.014), TR (p = 0.046) and GST (p = 0.044) were increased 
at day seven. AFB1 significantly increased the expression of Nrf2 (p = 0.029) 
and decreased the expression of Acc (p = 0.005) at day one. This study 
revealed that AFB1 disrupts hepatic mitochondrial lipids and antioxidant 
capacity. These changes were dependent on the timing of exposure and did not 
follow a linear time-course trend. These alterations could be part of the 
hepatic mitochondria response mechanism to acute AFB1 toxicity. 
Introduction 
Aflatoxins are compounds that are produced as secondary metabolites of fungi 
belonging to the Aspergillus species particularly Aspergillus 
flavus, parasiticus, and nominus (Mutegi et al., 2018). These fungi thrive well 
in the Tropical climate where they grow on foodstuffs from farm to table 
(Gong and Watson, 2016; Mutegi et al., 2018). Hence, aflatoxins contaminate 
food and feed stuff especially cereals and nuts in sub-Saharan Africa and 
southeast Asia (Wild and Gong, 2009; Gong and Watson, 2016; Opoku et al., 
2018; Rushing and Selim, 2018). There are about 18 types of aflatoxins; 
however, the major ones are AFB1, AFB2, AFG1, AFG2, AFM1, and AFM2 
(Luo et al., 2018). Of these, AFB1 is the most toxic and prevalent and has been 
named a class 1 carcinogen by the International Agency for Research on 
Cancer (IARC) (Ostry et al., 2017). AFB1 has been shown to affect several 
organs and tissues; however, the liver is its target organ, where it has been 
shown to cause hepatocellular carcinoma (HCC) after chronic exposure 
(Wogan et al., 2012; Rushing and Selim, 2018). It is also mutagenic, 
teratogenic, immunotoxic (Bondy and Pestka, 2000; Rushing and Selim, 
2018), impairs growth in children (Khlangwiset et al., 2011; Watson et al., 
2018) and affects reproductive health (Eze et al., 2018). 
AFB1 is usually converted by the microsomal CYP450 family of enzymes to a 
more toxic epoxide, AFB1-8,9-epoxide (AFBO) (Deng et al., 2018). This highly 
reactive epoxide is responsible for the majority of the tissue toxicity of AFB1 
because it binds to macromolecules such as DNA and proteins (Rushing and 
Selim, 2018). To be fully detoxified, the epoxide crosses the mitochondria 
membrane where it goes through phase II metabolism by the detoxification 
enzymes such as glutathione transferases (GSTs) (Deng et al., 2018). Apart 
from its detoxification functions, the mitochondrion is also involved in other 
biological processes such as the oxidation process by the electron transport 
chain and production of reactive oxygen species (Bhat et al., 2015; Wang et al., 
2017). Hence, the critical roles that mitochondria play in the metabolism and 
detoxification of aflatoxin make it important in the pathogenesis of 
aflatoxicosis and therefore requires detailed investigation. Previous studies 
have shown that AFB1 impairs mitochondria function such as mitochondrial 
permeability (Liu and Wang, 2016; Wang et al., 2017). The permeability of the 
membrane is due in part to membrane transporters and its lipid composition 
(Van Meer et al., 2008). We and others have previously shown that AFB1 
disrupts lipid metabolism and induces oxidative stress (Lu et al., 2013; El-
Nekeety et al., 2014; Rotimi et al., 2016, 2017, 2018; Zhang et al., 2016). The 
balance of homeostasis within these two biochemical processes is important to 
the optimal function of mitochondria. 
Although acute aflatoxicosis occurs only occasionally when compared with 
chronic exposure, such acute exposures, which often lead to death, have been 
reported in Kenya and Tanzania (Ngindu et al., 1982; Azziz-Baumgartner et 
al., 2005; Lewis et al., 2005; Kamala et al., 2018). Hence, it is important to 
understand the time-course events associated with acute exposure to AFB1. 
Due to the essential role of mitochondria in the detoxification of AFB1 and 
pathogenesis of aflatoxicosis, we hypothesize that mitochondria oxidative 
stress and dyslipidemia will be associated with it in a time-dependent manner. 
The aim of this study, therefore, was to investigate the time course effects of 
subacute AFB1 hepatotoxicity in albino Wistar rats. We achieve this by 
studying the changes in liver function, mitochondrial lipids and oxidative 
stress as well as the expression of genes associated with lipid metabolism and 
oxidative stress. 
Materials and Methods 
Chemicals 
AFB1 and other chemicals including mannitol, sucrose, HEPES, succinate, 
ethylenediaminetetraacetic acid (EDTA) used in this study were products of 
Sigma–Aldrich (St. Louis, MO, United States). The RNA extraction kit was a 
product of Aidlab® Biotechnologies Co., Ltd., (Beijing, China). 
Animals 
Thirty male inbred albino Wistar rats weighing between 100–120 g were used 
for this study. They were housed at room temperature and allowed access to 
food and water ad libitum. The animals were acclimatized to the experimental 
condition for 2 weeks before the commencement of exposure. The experiment 
was conducted, and the animals cared for according to the institutional animal 
care and use committee guidebook and as approved by the Covenant 
University Ethical committee. 
Experimental Design 
The animals were randomly divided into six groups of five animals each, and 
they received an oral gavage dose of AFB1 (1 mg/kg body weight) in olive oil or 
olive oil only (controls) once daily for one, four, or seven days as shown below; 
AFB1 day 1: 1 mg/kg AFB1 for one day. 
Control day 1: Olive oil for one day. 
AFB1 day 4: 1 mg/kg AFB1 for four days. 
Control day 4: Olive oil for four days. 
AFB1 day 7: 1 mg/kg AFB1 for seven days. 
Control day 7: Olive oil for seven days. 
The animals were sacrificed 24 h after the last dose and blood was collected by 
cardiac puncture into heparinized tubes. A portion of the liver was kept in 
RNAlater® (Qiagen) for RNA extraction while the remaining part was 
immediately transferred into the mitochondria isolation buffer. The blood was 
centrifuged at 3000 rpm for 15 min to obtain the plasma. 
Preparation of Liver Mitochondria 
Liver mitochondria were isolated as described by Gogvadze et al. (2004). The 
liver was removed immediately after sacrifice and rinsed in freshly prepared 
ice-cold (4°C) homogenizing buffer (210 mM mannitol, 70 mM sucrose, 5 mM 
HEPES, and 1 mM EDTA pH 7.5) to remove blood. A 10% homogenate was 
then prepared after which the homogenate was centrifuged (600 × g, 8 min, 
4°C) to remove nuclei and unbroken cells. The resulting supernatant was 
centrifuged (5500 × g, 15 min, 4°C) to form the mitochondria pellet while the 
supernatant represented the cytosolic fraction. The pellet was suspended in 
about 0.3 ml of the buffer and then diluted with the homogenizing buffer 
(excluding 1 mM EDTA) after which it was centrifuged again (5500 × g, 15 
min, 4°C). The final mitochondria pellet was suspended in about 1 ml of the 
same buffer and protein concentration was determined according to the 
method of Lowry et al. (1951). The resulting mitochondrial and cytosolic 
fractions were used for further analysis. 
Biochemical Analysis 
Biomarkers of Liver Function 
Alkaline phosphatase (ALP), alanine transaminase (AST), and bilirubin were 
determined spectrophotometrically using Randox kits according to 
manufacturer’s instructions. 
Mitochondrial Cholesterol and Triacylglycerol 
Lipid was extracted from the liver mitochondria according to the method 
of Folch et al. (1957). The extract obtained was used for determining 
triacylglycerol and cholesterol spectrophotometrically, using commercially 
available kits, as described by Rotimi et al. (2012). 
Mitochondrial and Cytosolic Oxidant/Antioxidant Status 
Malondialdehyde (MDA) concentration was determined using the method 
of Buege and Aust (1978) by measuring the concentration of thiobarbituric 
acid reactive substances (TBARS). Nitric oxide (NO) concentration was 
determined using a method described by Yucel et al. (2012). Glutathione 
(GSH) concentration was determined using the method described by Ellman 
(1959), while glutathione peroxidase (GPx) activity was determined using the 
method of Rotruck et al. (1973). Glutathione S-transferase (GST) activity was 
determined according to the method of Habig et al. (1974) while superoxide 
dismutase (SOD) activity was determined using the pyrogallol autoxidation 
method by Marklund and Marklund (1974). Glutathione reductase (GR) was 
assayed using oxidized glutathione (GSSG) in the method described by Mavis 
and Stellwagen (1968) while thioredoxin reductase (TR) was determined as 
described by Holmgren and Bjornstedt (1995). 
Mitochondrial ATPase, NADH-Cytochrome C Reductase and 
Succinate Dehydrogenase 
Mitochondrial total ATPase was determined using the Taussky and Shorr, 
1953 method. Mitochondrial sample equivalent to 50 μg protein was added to 
a reaction mixture of 2 M NaCl solution and 24 mM Tris–HCl Buffer 
containing 0.68 mM EDTA and 6.0 mM MgCl2. The mixture was centrifuged 
and the supernatant obtained was added to Taussky-Shorr reagent. The 
mixture which was incubated at 25°C for 5 min after which absorbance was 
taken at 660 nm. 
Succinate dehydrogenase assay was carried out using the method described 
by Reisch and Elpeleg (2007). Mitochondrial sample equivalent to 10 μg 
protein was preincubated in 0.1 M phosphate buffer (pH 7.4) with 0.2 M 
succinate for 20 min at 25°C. After incubation, 0.2 M potassium cyanide, 
freshly prepared 5 mM 2,6-Dichlorophenolindophenol and 65 mM phenzine 
methosulfate were added and absorbance read at 660 nm. 
NADH – Cytochrome C reductase (complex I-III) was determined as 
described by Navarro et al. (2004). Mitochondria sample equivalent to 50 μg 
protein was added to 0.1 M phosphate buffer (pH 7.4) containing 0.2 mM 
NADH and 1 mM KCN. The reaction was then initiated by the addition of 0.1 
mM cytochrome C and absorbance was measured every minute for 3 min at 
550 nm. 
Extraction of RNA and Real-Time Quantitative Polymerase 
Reaction(RT-qPCR) 
RNA was extracted from the liver as previously described by Rotimi et al. 
(2017) after which the concentration and purity were checked using a 
NanoDrop spectrophotometer. 0.5 μg of RNA was reverse transcribed for 
complementary DNA (cDNA) synthesis using Bio Rad iScript cDNA. The 
cDNA was diluted 1:10 after which the qPCR was performed on the Bio Rad 
CFX96 Real-time PCR detection system using iQ SYBR Green Supermix kit 
and gene-specific primers for Nrf2, Acc, Hmgcoa, and Nqo1 genes (Table 1). 
The samples were analyzed in triplicates and two housekeeping genes (β-
actin and Gapdh) and an internal control were used. The relative expression 
of the genes was calculated using the 2-ΔΔCt method (Livak and Schmittgen, 
2001). 
TABLE 1 
 
Table 1. Sequence of gene specific primers for RT-qPCR. 
Statistical Analysis 
Results were analyzed using SPSS. Two-tailed T-test was used to determine 
the difference between the control and treatment group at each time point. 
ANOVA was used to determine the difference between all the groups with post 
hoc pairwise comparisons by Duncan’s multiple range test. 
Results 
Time course effects of subacute AFB1 exposure significantly increased plasma 
ALP (Figure 1B) at day 1 (control vs. treatment) (p = 0.028) and day 7 (p = 
0.046) while there was no significant difference in ALT (Figure 1A) between 
the control and treatment groups at all time points. Although there was no 
statistically significant difference in plasma bilirubin (control vs. treatment) at 
any time point, bilirubin concentration resulting from AFB1 treatment for 7 
days was significantly (p < 0.05) higher than that of day 1 and/or 4 days 
(Figure 1C). 
FIGURE 1 
 Figure 1. Time course effects of sub-acute AFB1 exposure 
on (A) ALT, (B) ALP, and (C) total bilirubin. P-values <0.1 are shown for 
comparisons between control and AFB1 at a given time point, and p < 0.05 is 
considered significant. Bars represent mean ± SEM (n = 5). 
Sub-acute AFB1 exposure disrupts mitochondrial lipids and oxidative stress. 
AFB1 (1.0 mg/kg) significantly increased mitochondrial cholesterol (p = 
0.016) after exposure for 7 days while there was no significant difference in 
mitochondrial triacylglycerols (Figure 2). The time course effects of subacute 
AFB1 exposure on mitochondrial oxidant/antioxidant status are depicted 
in Figure 3. AFB1 exposure significantly increased GSH (p = 0.025) at day 1 
while NO (p = 0.048) and MDA (p = 0.058) were increased at day 7. GST (p = 
0.030) and TR (0.014) were also significantly increased as a result of AFB1 
exposure after 7 days of exposure. NO, MDA, GST, and GPx of the treatment 
group at day 7 was significantly (p < 0.05) higher than that of day 4. There was 
no significant difference in mitochondrial SOD on all the days. 
FIGURE 2 
 
Figure 2. Time course effects of sub-acute AFB1 exposure on 
mitochondrial (A) cholesterol and (B) triacylglycerol. Significant p-values 
(p < 0.05) for control vs. AFB1 at a given time point are shown. Bars represent 
mean ± SEM (n = 5). 
FIGURE 3 
 
Figure 3. Time course effects of sub-acute AFB1 exposure on 
mitochondrial (A) GSH, (B) MDA, (C) SOD, (D) NO, (E) GST, (F) GPx, (G) 
GR, and (H) TR. P-values <0.1 are shown for comparisons between control 
and AFB1 at a given time point, and p < 0.05 is considered significant. Bars 
represent mean ± SEM (n = 5). 
The time course effects of subacute AFB1 exposure on the oxidant/antioxidant 
status of the cytosolic fractions are depicted in Figure 4. AFB1 significantly 
increased MDA at only day 1 (p = 0.003) while GST (p = 0.044), GR (0.014), 
and TR (0.046) were significantly increased at day 7. In the cytosolic fractions, 
AFB1 exposure at day 7 significantly (p < 0.05) increased MDA, GST, TR, and 
GPx when compared with AFB1 exposure at day 1. There was no significant 
difference in cytosolic SOD on all the days. 
FIGURE 4 
 
Figure 4. Time course effects of sub-acute AFB1 exposure on 
cytosolic (A) GSH, (B) MDA, (C) SOD, (D) NO, (E) GST, (F) GPx, (G) GR, 
and (H) TR. P-values <0.1 are shown for comparisons between control and 
AFB1 at a given time point, and p < 0.05 is considered significant. Bars 
represent mean ± SEM (n = 5). 
Time course subacute AFB1 exposure on mitochondrial enzymes are shown 
in Figure 5. AFB1 significantly increased ATPase (p = 0.036) while it 
decreased succinate dehydrogenase at day 1 (p = 0.016). AFB1 also increased 
NADH-Cyt C (p = 0.058) at day 7 only. 
FIGURE 5 
 
Figure 5. Time course effects of sub-acute AFB1 exposure on 
mitochondrial (A) ATPase, (B) NADH-Cyt C, and (C) Succinate 
dehydrogenase. P-values <0.1 are shown for comparisons between control and 
AFB1 at a given time point, and p < 0.05 is considered significant. Bars 
represent mean ± SEM (n = 5). 
The time course effects of AFB1 on the relative expression of genes associated 
with oxidative stress are shown in Figure 6. AFB1 increased Nrf2 (p = 0.029) 
and Hmgcoa (p = 0.061) at day 1 while Acc (0.005) was significantly 
decreased at day 1. 
FIGURE 6 
 
Figure 6. Time course effects of sub-acute AFB1 exposure on relative 
expression of (A) Nrf2, (B) Acc, (C) Hmgcoa, and (D) Nqo1 in liver. P-values 
<0.1 are shown for comparisons between control and AFB1 at a given time 
point, and p < 0.05 is considered significant. Bars represent mean ± SEM (n = 
3). 
Discussion 
Time-course effects of subacute AFB1 exposure for 1, 4, and 7 days increased 
biomarkers of liver function, mitochondrial cholesterol, mitochondrial oxidant 
status (MDA and NO) as well as increased the enzymic and non-enzymic 
antioxidant status. These changes were associated with upregulation 
of Nrf2 and downregulation of Acc at day 1. These changes were dependent on 
the timing of exposure but did not follow a linear time-course trend. Most of 
the changes observed in this study were at day 1 (initial exposure) or at day 7 
(last exposure). The changes at day 1 may be an initial response to toxic AFB1. 
This initial response was characterized by increases in liver ALP, 
mitochondrial GSH concentrations, ATPase activity, cytosolic MDA, 
liver Nrf2 expression, and decreases in mitochondrial succinate 
dehydrogenase activity and liver Acc expression. The changes collectively, may 
represent the initial protective response of the mitochondria against the 
aflatoxin toxicity. At the end of the time course, changes between exposed and 
controls included increases in ALP and bilirubin, mitochondrial MDA, NO, 
and GST activity, and cytosolic GST, GR, and TR activity. These outcomes may 
reflect an overwhelmed response system with increased toxicity manifesting in 
the liver. 
In this study, AFB1 significantly increased the activity of ALP at day 1 and day 
7 when compared with controls while the concentration of bilirubin in AFB1 
exposed group at day 7 was significantly higher than those of day 1 and day 4. 
The concentrations of ALT, ALP, and bilirubin are usually increased in the 
plasma in response to hepatic injury which allows them to leak out into the 
plasma. Although plasma ALT activity is considered a gold standard for 
measuring liver injury, ALP, GGT, and total bilirubin are biomarkers used in 
addition to ALT especially in relation to conventional biliary action. Studies 
have shown that during biliary cirrhosis, there could be increases in ALP and 
GGT without corresponding increase in ALT (Ramaiah, 2007; Ozer et al., 
2008). Although we did not assay for GGT in this study, the increase in ALP 
and bilirubin observed in this study suggests that liver injury may be 
associated with the hepatobiliary action and tends towards cholestatic 
induction. During the progression of cholestasis, increases in cholestatic 
induction enzymes such as ALP usually precedes an increase in bilirubin 
(Ramaiah, 2007). Several studies have reported increases in these biomarkers 
following AFB1 exposure (El-Nekeety et al., 2014; Rotimi et al., 
2016; Eftekhari et al., 2018). Redzwan et al. (2014) found a positive 
correlation between AFB1-lysine adducts and total bilirubin in Malaysian 
adults. While ALP is localized within the cell membrane of tissues, ALT could 
be found in the cytoplasm and mitochondria, and changes in membrane 
permeability due to lipid accumulation could allow these enzymes to leak out 
into the cytosol. 
AFB1 significantly increased mitochondrial cholesterol at day 7. Of all cellular 
compartments, the mitochondrion is considered to have low cholesterol 
concentration. It contains about 0.5–3% of cholesterol found in other 
organelles (Ikonen, 2008; Van Meer et al., 2008). Cholesterol is an essential 
component of the mitochondrial membrane, and increased accumulation of 
cholesterol in the mitochondria decreases its membrane’s fluidity and 
consequently its permeability (Ikonen, 2008; Van Meer et al., 2008). The 
increase in mitochondrial cholesterol observed in this study may be one of the 
mechanisms by which AFB1 affects the mitochondria and induces toxicity. 
Increase in mitochondrial cholesterol has been suggested to aggravate 
cholestasis (Nuño-Lámbarri et al., 2016). Apart from cholestasis, recent 
evidence showed that elevated mitochondria cholesterol might be involved in 
other diseases associated with the liver such as steatohepatitis and progression 
of HCC (García-Ruiz et al., 2016). Therefore, elevated mitochondria 
cholesterol may be one of the events associated with AFB1 induced HCC. Since 
we report evidence for this after only 7 days of exposure, this needs to be 
further studied in a chronic exposure experiment beyond 7 days. It is worthy 
of note that the increase in mitochondrial cholesterol was not associated with 
increased expression of Hmgcr. Although there was no significant increase in 
expression of Hmgcr gene at day 7, a nearly significant (p = 0.061) increase 
was observed at day 1. Vohra et al. (1985) found that acute AFB1 exposure 
increased mitochondrial cholesterol in rats after a single dose with higher 
concentration (5 mg/kg) given intraperitoneally. 
Elevated mitochondria cholesterol negatively affects several membrane 
carriers. An example is the GSH transport system responsible for the transport 
of GSH from the cytosol- where it is synthesized- to the mitochondria through 
an ATP-dependent process (Fernandez-Checa and Kaplowitz, 2005). In this 
study, mitochondrial GSH (mGSH) was significantly increased at day 1 while 
there was no significant difference at day 7. The increase in GSH at day 1 also 
corresponds with the increase in ATPase observed at day 1. Although the 
transport of GSH is controlled by mitochondrial cholesterol concentration 
through an ATP-dependent process, it is worthy of note that the changes in 
mitochondrial cholesterol, GSH and ATPase did not occur at the same time. It 
is possible that these changes precede one another, while significant changes 
in GSH and ATPase were observed at day 1, significant increases in cholesterol 
were observed at day 7. 
GSH together with mitochondrial antioxidant enzymes are responsible for 
maintaining the oxidant/antioxidant status of the mitochondria considering 
its role in electron transport chain and the generation of free radicals (reactive 
oxygen/nitrogen species) (Bhat et al., 2015). In this study AFB1 induced 
mitochondrial oxidative/nitrosative stress as shown by the increase in 
mitochondrial MDA and NO at day 7. Surprisingly, the increase in MDA and 
NO were associated with an increase in mitochondria GST and TR. It is 
expected that increase in MDA and NO will be associated with a decrease in 
antioxidant enzymes; however, it seems that the increase in GST and TR 
observed may be an attempt to counter the increase in oxidative/nitrosative 
species in this acute exposure. During aflatoxin metabolism, GST catalyzes the 
conjugation of AFBO with GSH for onward detoxification. The observed 
increase in GST may be a protective measure in response to subacute AFB1 
exposure. 
In the same vein, although increase in thioredoxin reductase (TR) seems to 
play a role in protecting against oxidative stress, other studies show that 
thioredoxin in reduced form may support the growth of cancer cells by 
complexing with apoptosis signaling kinase 1 (ASK1), which then prevents 
apoptosis (Arnér and Holmgren, 2000). Rieswijk et al. (2016) found that 
repetitive AFB1 (0.3 μM) exposure for 5 days led to persistent 
hypomethylation and upregulation of TR-1 –which has been shown to be 
associated with AFB1 and related to the development of HCC- in primary 
human hepatocytes (Caiment et al., 2014). Our study showed that AFB1 
significantly increased the activity of mitochondrial and cytosolic TR at day 7. 
Considering the similar increase observed in other antioxidants in this study, 
it seems that the increase in TR activity plays a role in preventing against 
AFB1-induced oxidative stress. 
On the other hand, this increased activity may be as a result of AFB1-induced 
hypomethylation and upregulation of TR (Rieswijk et al., 2016) and adequate 
availability of selenium (a cofactor of TR) whose deficiency has been shown to 
protect against aflatoxicosis in rats (McLeod et al., 1997). To the best of our 
knowledge, this study is the first to report the activity of TR in response to 
subacute AFB1 exposure in rats. Zhang et al. (2016), using RNA-Seq, studied 
the hepatic transcriptome of ducklings in response to AFB1 after 2 weeks of 
exposure. They found that TR, GSTs, and Nqo1 were upregulated 
while Acc was down-regulated. This is similar to the results observed in this 
study, our results showed that AFB1 downregulated Acc at day 1 only. Acc is 
associated with the promotion of fatty acid synthesis, and we have previously 
shown that subacute exposure to AFB1 for seven days increased plasma free 
fatty acid (FFA) due to downregulation of CPT1 necessary for transporting 
fatty acids into the mitochondria for ß oxidation (Rotimi et al., 2017). 
Nrf2 is a transcription factor usually activated in response to reactive oxygen 
species. Apart from its role in antioxidant defense, it has also been shown to 
play a role in hepatic lipid metabolism (Shimpi et al., 2017). In this study, we 
found that AFB1 upregulated the expression of Nrf2 at day 1 alone. This 
increase was in response to increased oxidant status and an attempt to 
maintain the oxidant/antioxidant status balance. Nrf2 does this by 
upregulating other antioxidant enzymes particularly the phase II 
detoxification enzymes. Although we did not determine the expression of 
these enzymes, their activities were increased. The increase in Nrf2 was 
associated with increased GST both in the mitochondrial and cytosolic 
compartments. AFB1 (0.5–5 μmol/L) upregulated Nrf2 in broiler hepatocytes 
and cardiomyocytes after exposure for 24–72 h (Liu and Wang, 2016; Wang et 
al., 2017). Recently, Muhammad et al. (2018) found that exposure of broilers 
to AFB1 (5 mg/kg feed) for 28 days significantly downregulated Nrf2. Their 
result differs from ours, and this could be a result of exposure (subacute vs. 
subchronic) and species (rat vs. broiler) differences. 
In this study AFB1 significantly decreased hepatic succinate dehydrogenase 
(SDH) at day 1. Our results are similar to other studies such as that of Rastogi 
et al. (2001) where they observed a 16% decrease in SDH after a single dose of 
AFB1 (2 mg/kg) in rats. A similar trend was also observed in birds (Quezada et 
al., 2000). Acute AFB1 exposure of rats to a single dose of AFB1 (7 mg/kg bw) 
significantly decreased SDH after 12 h of exposure after which the activity of 
SDH returned to normal (Sajan et al., 1995). Vohra et al. (1985) also observed 
a significant decrease in the activity of liver SDH 6 to 24 h after a single dose 
of AFB1 (5 mg/kg) in rats. They observed that the effect of AFB1 on SDH was 
time-dependent and maximum decrease was observed 24 h after treatment. 
Strengths of this study include, time course and the biomarkers used to assess 
oxidative damage particularly TR activity, which has been reported to play a 
dual role in protecting against oxidative damage but also in driving cellular 
carcinogenesis. This study was limited by the sample size (5 in each group) 
which may have limited our statistical power to detect all true significant 
differences between groups. Although the dosage used is higher than that 
reported in human exposure; our previous study established this dosage to be 
adequate for eliciting toxic response in rats, without causing death. In 
addition, we analyzed expression of four genes implicated in response to AFB1 
out of many possible. Future research should assess the effects of acute AFB1 
over several days or weeks on animals of both sexes and multiple ages (adults 
and young) to determine critical windows in the time course of toxicity that 
mimic populations exposed to highly contaminated foods. 
Conclusion 
In conclusion, subacute exposure to AFB1 showed different sets of responses 
at day 1 and after 7 days of exposure. We showed that AFB1 significantly 
increased biomarkers of liver functions and oxidative stress which was 
associated with increased mitochondrial lipids. Interestingly, we also observed 
an increase in mitochondrial antioxidant enzymes and particularly, we showed 
for the first time that subacute AFB1 exposure increased thioredoxin reductase 
activity in both cytosolic and mitochondrial compartments. 
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